Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Andrea Duchini"'
Publikováno v:
Annals of Hepatology, Vol 11, Iss 3, Pp 326-329 (2012)
Background and aims. Despite effective vaccine available, hepatitis A remains a significant cause of morbidity and mortality worldwide including acute liver failure, transplantation and death. Vaccination rates for hepatitis A in the general populati
Externí odkaz:
https://doaj.org/article/d0c69a17addc4461a692ee40952636ad
Autor:
Rishi R. Bhardwaj, Andrea Duchini
Publikováno v:
Case Reports in Gastroenterology, Vol 4, Iss 1, Pp 100-103 (2010)
Myotonic dystrophy is a multisystemic disorder characterized by repeat expansion mutations of the dystrophia myotonica protein kinase (DMPK) gene resulting in a defective muscular insulin receptor and insulin resistance. We describe a patient with my
Externí odkaz:
https://doaj.org/article/b4647de75bc84fdaaa855e2aebd4f201
Autor:
Praveen Guturu, Andrea Duchini
Publikováno v:
International Journal of Hepatology, Vol 2012 (2012)
Incidence of nonalcoholic fatty liver disease is increasing with an estimated prevalence of 20–30% in developed nations. This is leading to increased incidence of chronic liver disease, cirrhosis, and hepatocellular cancer. It is critical to unders
Externí odkaz:
https://doaj.org/article/2d9395fdaea44f34a0c99685a8787a8f
Autor:
Mukul K. Divatia, Duc T. Nguyen, Robert S. McFadden, David W. Victor, Andrea Duchini, Constance M. Mobley, Julius Balogh, R. Mark Ghobrial, Kirk Heyne, A. Osama Gaber, Victor Ankoma-Sey, Howard Paul Monsour, Keri E. Lunsford, Maha Boktour, Chukwuma Egwim, Joseph S. Galati, Ashish Saharia, Edward A. Graviss
Publikováno v:
Transplantation. 104:113-121
Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor. Currently, liver transplantation may be the optimal treatment for HCC in cirrhotic patients. Patient selection is currently based on tumor size. We developed a program t
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Pancreatic rhabdomyosarcoma is an extremely rare disease. • Pre-operative diagnosis is challenging due to unspecific presentation. • Surgical resection followed by chemotherapy and radiotherapy are the only possible treatments. •
Autor:
Craig P. Fischer, A. Osama Gaber, Barbara L. Bass, Stephen L. Jones, Thomas A. Aloia, Bridget N. Fahy, Joseph Galati, R. Mark Ghobrial, Andrea Duchini
Publikováno v:
HPB. 11(6):510-515
Background For the past two decades multiple series have documented that liver resection has become safer. The purpose of this study was to determine the current status of hepatic resection in the USA by analysing the multi-institutional experience w
Publikováno v:
Clinical Microbiology Reviews. 16:357-364
SUMMARY Recipients of solid-organ transplantation are at risk of severe infections due to their life-long immunosuppression. Despite emerging evidence that vaccinations are safe and effective among immunosuppressed patients, most vaccines are still u
Autor:
Andrea Duchini, Eric Viernes, Robert McMillan, Paul J. Pockros, Lisa M. Nyberg, John G. McHutchison
Publikováno v:
The American Journal of Gastroenterology. 97:2040-2045
OBJECTIVE: Hepatitis C virus (HCV) infection has been associated with the production of autoantibodies and the development of several autoimmune disorders. Immune thrombocytopenic purpura (ITP) is an immune-mediated syndrome of unknown etiology chara
Autor:
Jianli Dong, Luca Cicalese, Andrea Duchini, Nihal E. Abdulla, Roger D. Soloway, Cristiana Rastellini, Anthony O. Okorodudu, Gengming Huang, Hyunsu Ju, Albert P. Li, Joseph D. Krocker, John R. Petersen, Peter Hu, Lucas R. Wieck, Shehzad Merwat, Jason L. Kirk
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 52
Background Hyper-methylation of CpG dinucleotides in the promoter region of inhibitor of cyclin-dependent kinase 4A (INK4A) has been reported in 60%-80% of hepatocellular carcinoma (HCC). As INK4A promoter hypermethylation event occurs early in HCC p
Publikováno v:
The American Journal of Gastroenterology. 95:3238-3241
OBJECTIVE: LKM-positive, or type 2, autoimmune hepatitis is characterized by the presence of antibodies directed against liver–kidney microsomes (LKM1). Although described frequently in southern Europe and the Mediterranean, this subtype of autoimm